A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II

This study is not yet open for participant recruitment.

Verified August 2010 by National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor:

Collaborators:

Immune Tolerance Network (ITN)

Juvenile Diabetes Research Foundation

Information provided by:

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov Identifier:

NCT01183455

First received: August 16, 2010

Last updated: NA

Last verified: August 2010

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	November 2014
Estimated Primary Completion Date:	November 2013 (Final data collection date for primary outcome measure)